Skip to main content

Table 1 Study inclusion criteria

From: Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study

• Age 18 to 40 years

• GFR ≥ 70 ml/min (Cockcroft - Gault formula)

• Diagnosis of ADPKD:

    Positive family history for ADPKD

■ patients < 30 years: ≥ 2 cysts in either kidney

■ patients ≥ 30 years: ≥ 2 cysts in each kidney

    Negative family history for ADPKD but sonographically cystic kidney disease: proof of a mutation in the PKD1 or PKD2 gene is required (Athena Diagnostics, Inc., Worcester, MA, USA)

• Documented kidney volume enlargement (MRI volumetry)

• Signed informed consent